Seco 8
Seco 8 Brand names, Seco 8 Analogs
- (+/-)-Secobarbital
- Barbosec
- Bipanal
- Bipinal sodium
- DEA No. 2315
- DEA No. 2316
- Evronal
- Evronal Sodium
- Evrronal
- Hypotrol
- Hyptran
- Imesonal
- Immenoctal
- Immenox
- Meballymal
- Meballymal sodium
- Meballymalum
- Novosecobarb
- Pramil
- Quinalbarbital
- Quinalbarbitone
- Quinalbarbitone sodium
- Quinalspan
- Sebar
- Seco 8
- Secobarbital (USP)
- Secobarbital Sodium
- Secobarbital [USAN:INN]
- Secobarbital suppository dosage form
- Secobarbitale [DCIT]
- Secobarbitalum [INN-Latin]
- Secobarbitone
- Seconal
- Seconal (TN)
- Seconal Sodium
- Sedutain
- Seotal
- Sodium Secobarbital
- Sodium Seconal
- Sodium quinalbarbitone
- Somosal
- Synate
- Trisomnin
Seco 8 Brand Names Mixture
- No information avaliable
Seco 8 Chemical_Formula
C12H18N2O3
Seco 8 RX_link
No information avaliable
Seco 8 fda sheet
Seco 8 msds (material safety sheet)
Seco 8 Synthesis Reference
No information avaliable
Seco 8 Molecular Weight
238.283 g/mol
Seco 8 Melting Point
100 oC
Seco 8 H2O Solubility
550 mg/L
Seco 8 State
Solid
Seco 8 LogP
1.879
Seco 8 Dosage Forms
Capsule
Seco 8 Indication
For the Short-term treatment of intractable insomnia for patients habituated to barbiturates
Seco 8 Pharmacology
Secobarbital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Seco 8 Absorption
No information avaliable
Seco 8 side effects and Toxicity
No information avaliable
Seco 8 Patient Information
No information avaliable
Seco 8 Organisms Affected
Humans and other mammals
